Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2025-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$140.7m
reported value
-8.5% vs Q1 2025
38positions
66.1%in top 10
3 new
3 added
1 reduced
1 sold out
vs Q1 2025
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ALDEYRA THERAPEUTICS INC ALDX | $21.0m14.91% | Unchanged |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $12.6m8.98% | Added +64.4k |
| ENTERA BIO LTD ENTX | $11.2m7.95% | Unchanged |
| SPDR GOLD TR GLD | $9.8m6.94% | Unchanged |
| MEIRAGTX HLDGS PLC MGTX | $8.2m5.79% | Unchanged |
| KINROSS GOLD CORP KGC | $6.9m4.89% | Unchanged |
| AGNICO EAGLE MINES LTD AEM | $6.6m4.69% | Unchanged |
| SANDSTORM GOLD LTD SSL | $6.6m4.68% | Unchanged |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $5.3m3.78% | Unchanged |
| ELICIO THERAPEUTICS INC ELTX | $4.9m3.46% | Unchanged |
| SKEENA RES LTD NEW SKE | $4.7m3.34% | Reduced -20.0k |
| SEABRIDGE GOLD INC COM | $4.6m3.27% | Unchanged |
| ALTIMMUNE INC ALT | $4.3m3.09% | Unchanged |
| FRANCO NEV CORP FNV | $4.1m2.91% | Unchanged |
| MAG SILVER CORP MAG | $3.6m2.55% | Unchanged |
| NUVATION BIO INC NUVB | $2.9m2.08% | Unchanged |
| ISHARES SILVER TR SLV | $2.6m1.87% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $2.4m1.72% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $1.9m1.32% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.8m1.29% | Unchanged |
| VISA INC V | $1.7m1.22% | Unchanged |
| ROYAL GOLD INC RGLD | $1.6m1.14% | Added +1.4k |
| ISHARES TR ITA | $1.4m1.03% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.4m0.96% | Unchanged |
| ALAMOS GOLD INC NEW AGI | $1.3m0.94% | Added +9.0k |
| WHEATON PRECIOUS METALS CORP WPM | $1.1m0.80% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $1.1m0.77% | Unchanged |
| COEUR MNG INC CDE | $851.7k0.61% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $705.9k0.50% | Unchanged |
| DIAGEO PLC DEO | $680.7k0.48% | Unchanged |
| VERONA PHARMA PLC VRNA | $666.7k0.47% | Unchanged |
| NEW PAC METALS CORP NEWP | $649.9k0.46% | Unchanged |
| HOOKIPA PHARMA INC COM | $625.8k0.44% | Unchanged |
| ABEONA THERAPEUTICS INC ABEO | $356.1k0.25% | New |
| CENTERRA GOLD INC CGAU | $170.3k0.12% | New |
| ORCHESTRA BIOMED HLDGS INC OBIO | $169.8k0.12% | New |
| CARDIOL THERAPEUTICS INC CRDL | $136.0k0.10% | Unchanged |
| Orgenesis, Inc. COM | $74.7k0.05% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| EQUINOX GOLD CORP EQX | $3.8m550.8k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |